You are here

Eravacycline

Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback

Xconomy

Wed, 02/14/18 - 11:43 am

Tetraphase Pharmaceuticals

clinical trials

Tetraphase Pharmaceuticals Antibiotic Fails Against J&J Drug In Trial; Stock Plunges 79% After-Hours

Bidness, ETC

Wed, 09/9/15 - 08:07 am

Tetraphase Pharmaceuticals

3 Biotech Stocks to Buy With Huge Catalysts Coming Soon

24/7 Wall St

Mon, 08/3/15 - 12:17 pm

Tetraphase Pharmaceuticals

Tetraphase spikes on a Phase III success for lead antibiotic

Fierce Biotech

Wed, 12/17/14 - 09:41 pm

Tetraphase Pharmaceuticals

Tetraphase Oral Antibiotic Data Look Good

TheStreet.com

Wed, 09/3/14 - 08:03 am

Tetraphase Pharmaceuticals

Previewing Tetraphase Oral Antibiotic Study Results

TheStreet.com

Wed, 08/27/14 - 08:20 am

Tetraphase Pharmaceuticals

urinary tract infection

Tetraphase Pharmaceuticals: A Small Cap With Big Potential

Seeking Alpha

Sat, 01/4/14 - 04:14 pm

Tetraphase Pharmaceuticals

Cubist Pharmaceuticals

FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate

Yahoo

Mon, 07/15/13 - 10:29 am

Tetraphase Pharmaceuticals